American Origin Unverified
This profile is unclaimed and has not been independently reviewed.
Claim & get verified
Translational Development Acquisition Corp.
$10.76
+0.19%
NASDAQ: TDAC · 15-min delayed
$235.3MMarket cap
$6.4MNet income
TDACNASDAQ
2025IPO
About Translational Development Acquisition Corp.
Translational Development Acquisition Corp is a newly organized blank check company.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Reported figures
Financial summary
- Net income
- $6.4M
- Total assets
- $181.7M
- Market cap
- $235.3M
Source: SEC EDGAR · updated Jun 8, 2026
Multi-year
Revenue & profit trend
FY2018
FY2019
FY2020
FY2025
Revenue Net income
FY 2025
Financial statements
Income statement
- Operating income
- -$944.5K
- Net income
- $6.4M
Balance sheet
- Total assets
- $181.7M
- Current assets
- $39.5K
- Total liabilities
- $6.6M
- Current liabilities
- $544.1K
- Shareholders’ equity
- -$6.5M
Cash flow
- Operating cash flow
- -$608.4K
- Investing cash flow
- $408.4K
- Financing cash flow
- $200.0K
- Net cash flow
- $0
Statements via Polygon.io (SEC filings)
NASDAQ: TDAC
$10.76
+0.19%
15-minute delayed · data by Polygon.io
Past year
$10.17
$10.76
52-week range
- Market cap
- $235.3M
- Shares outstanding
- 21.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Feb 13, 2025
Market data by Polygon.io · prices are 15-minute delayed
Auto-generated
At a glance
- Profitable — net income of $6.4M.
- Trading near its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Translational Development Acquisition Corp..
Write a review
Newsroom
News about Translational Development Acquisition Corp.
News & sentiment via Polygon.io
Explore
Browse all →
